Our vision for our 340B division is simple.  We strive to implement and assist in any and all 340B related matters in order to improve the lives of indigent populations, and the healthcare providers that serve them.

 

The federal government’s 340B program is designed to promote access to affordable medications for the most vulnerable or underserved patient populations while helping to stretch federal; resources.  This program mandates that drug manufacturers must provide outpatient drugs at greatly discounted prices to certain qualifying hospitals and healthcare organizations.  Today, more than one-third of all hospitals nationwide participate in the 340B program and benefit from these drug discounts.  It is estimated that 95% of all marketed drugs have 340B discounts associated with them and the average savings is approximately 25-50% of wholesale pricing.

 

Specialty drugs are an important area for 340B programs, as these therapies tend to be higher in cost and the market for specialty medications is growing rapidly.  As a result, we frequently collaborate with qualified 340B hospitals and healthcare organizations, providing access to more affordable drugs while maintaining our unwavering focus on clinical excellence, patient education and premier service.

 

Fill in your contact information to learn more about the 340B federal program, our 340B solution and how we collaborate with 340B-qualifying organizations throughout the U.S.

 

Click here for our blog article about what the 340B program is about.